(-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC-1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity

International Journal of Oncology

Volumn 42, Issue 1, 2013, Pages 349-358

  Kim, Sung Ok ^a   Kim, Mi Ryeo ^a  

^a Daegu Haany University   (South Korea)

Author keywords

( ) epigallocatechin 3 gallate; AsPC 1 cells; Histone deacetylation; Invasion; Pancreatic adenocarcinoma; Raf kinase inhibitor protein

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; HISTONE DEACETYLASE; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRICHOSTATIN A; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPIGENETICS; HUMAN; HUMAN CELL; METASTASIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSLOCATION LINE; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ADENOCARCINOMA; APOPTOSIS; BLOTTING, WESTERN; CADHERINS; CATECHIN; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HISTONE DEACETYLASES; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NF-KAPPA B; PANCREATIC NEOPLASMS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84873653468     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1686     Document Type: Article

References (56)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Korea Ministry of Health and Welfare: Annual report of cancer statistics in Korea in 2008. http://mw.go.kr, 2011.
3. Warshaw AL, Gu ZY, Wittenberg J and Waltman AC: Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 125: 230-233, 1990. (Pubitemid 20060650)
4. Whitcomb DC: Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 287: G315-G319, 2004. (Pubitemid 38955250)
5. Tang H, Park S, Sun SC, Trumbly R, Ren G, Tsung E and Yeung KC: RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Lett 4: 662-668, 2009.
6. Yeung K, Janosch P, McFerran B, Rose DW, Mischak H, Sedivy JM and Kolch W: Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 20: 3079-3085, 2000. (Pubitemid 30215020)
7. Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, Peiró S, Baulida J, Francí C, Dedhar S, Larue L and García de Herreros A: Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23: 7345-7354, 2004. (Pubitemid 39382137)
8. Munshi HG and Stack MS: Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 25: 45-56, 2006. (Pubitemid 43723981)
9. Gregory PD, Wagner K and Horz W: Histone acetylation and chromatin remodeling. Exp Cell Res 265: 195-202, 2001. (Pubitemid 32980207)
10. Struhl K: Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12: 599-606, 1998. (Pubitemid 28134293)
11. Gray SG and Teh BT: Histone acetylation/deacetylation and cancer: an 'open' and 'shut' case? Curr Mol Med 1: 401-429, 2001.
12. Hayden MS and Ghosh S: Signaling to NF-κB. Genes Dev 18: 2195-2224, 2004.
13. Choi KC, Jung MG, Lee YH, Yoon JC, Kwon SH, Kang HB, Kim MJ, Cha JH, Kim YJ, Jun WJ, Lee JM and Yoon HG: Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res 69: 583-592, 2009.
14. Thakur VS, Gupta K and Gupta S: Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases. Int J Oncol 41: 353-361, 2012.
15. Choudhury SR, Balasubramanian S, Chew YC, Han B, Marquez VE and Eckert RL: (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells. Carcinogenesis. 32: 1525-1532, 2011.
16. Li Y, Yuan YY, Meeran SM and Tollefsbol TO: Synergistic epigenetic reactivation of estrogen receptor-a (ERa) by combined green tea polyphenol and histone deacetylase inhibitor in ERa-negative breast cancer cells. Mol Cancer 9: 274-286, 2010.
17. Yun JM, Jialal I and Devaraj S: Effects of epigallocatechin gallate on regulatory T cell number and function in obese v. lean volunteers. Br J Nutr 103: 1771-1777, 2010.
18. Fang M, Chen D and Yang CS: Dietary polyphenols may affect DNA methylation. J Nutr 137: 223S-228S, 2007. (Pubitemid 46052885)
19. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM and Kolch W: Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401: 173-177, 1999. (Pubitemid 29436321)
20. Ren G, Baritaki S, Marathe H, Feng J, Park S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R, Daignault S, Al-Mulla F, Keller E, Bonavida B, de la Serna I and Yeung KC: Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res 72: 3091-3104, 2012.
21. Minn AJ, Bevilacqua E, Yun J and Rosner MR: Identification of novel metastasis suppressor signaling pathways for breast cancer. Cell Cycle 11: 2452-2457, 2012.
22. Karamitopoulou E, Zlobec I, Panayiotides I, Patsouris ES, Peros G, Rallis G, Lapas C, Karakitsos P, Terracciano LM and Lugli A: Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Hum Pathol 42: 1888-1896, 2011.
23. Hu CJ, Zhou L, Zhang J, Huang C and Zhang GM: Immunohistochemical detection of Raf kinase inhibitor protein in normal cervical tissue and cervical cancer tissue. J Int Med Res 39: 229-237, 2011.
24. Zebisch A, Wölfler A, Fried I, Wolf O, Lind K, Bodner C, Haller M, Drasche A, Pirkebner D, Matallanas D, Rath O, Blyth K, Delwel R, Taskesen E, Quehenberger F, Kolch W, Troppmair J and Sill H: Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia. Leukemia 26: 1842-1849, 2012.
25. Wu K and Bonavida B: The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29: 241-254, 2009.
26. Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W and Sedivy JM: Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 21: 7207-7217, 2001. (Pubitemid 32953475)
27. Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663, 2000. (Pubitemid 30365393)
28. Emonds E, Fitzner B and Jaster R: Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells. World J Gastroenterol 16: 1970-1978, 2010.
29. Farrow B, Rychahou P, O'Connor KL and Evers BM: Butyrate inhibits pancreatic cancer invasion. J Gastrointest Surg 7: 864-870, 2003. (Pubitemid 37338549)
30. Hardtner C, Multhoff G, Falk W and Radons J: (-)-Epigallocatechin-3- gallate, a green tea-derived catechin, synergizes with celecoxib to inhibit IL-1-induced tumorigenic mediators by human pancreatic adenocarcinoma cells Colo357. Eur J Pharmacol 684: 36-43, 2012.
31. Choi KC, Lee YH, Jung MG, Kwon SH, Kim MJ, Jun WJ, Lee J, Lee JM and Yoon HG: Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol Cancer Res 7: 2011-2021, 2009.
32. Zucker S, Cao J and Chen WT: Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19: 6642-6650, 2000. (Pubitemid 32197703)
33. Mook OR, Frederiks WM and Van Noorden CJ: The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89, 2004. (Pubitemid 39592897)
34. Duffy MJ, Maguire TM, Hill A, McDermott E and O'Higgins N: Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2: 252-257, 2000. (Pubitemid 32223594)
35. Vihinen P, Ala-aho R and Kähäri VM: Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 5: 203-220, 2005. (Pubitemid 40694861)
36. Gibbs DF, Warner RL, Weiss SJ, Johnson KJ and Varani J: Characterization of matrix metalloproteinases produced by rat alveolar macrophages. Am J Respir Cell Mol Biol 20: 1136-1144, 1999. (Pubitemid 129503231)
37. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R and Nagayama M: Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 37: 65-71, 2001.
38. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J and García De Herreros A: The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumor cells. Nat Cell Biol 2: 84-89, 2000.
39. Jiao W, Miyazaki K and Kitajima Y: Inverse correlation of E-cadherin and Snail expression in hepatocellular cell lines in vitro and in vivo. Br J Cancer 86: 98-101, 2002. (Pubitemid 34146348)
40. Poser I, Domínguez D, de Herreros AG, Varnai A, Buettner R and Bosserhoff AK: Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repression Snail. J Biol Chem 276: 24661-24666, 2001.
41. Luo J, Lubaroff DM and Hendrix MJ: Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res 59: 3552-3556, 1999. (Pubitemid 29381850)
42. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M and Mori T: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701, 1993. (Pubitemid 23113254)
43. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE and Baylin SB: E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199, 1995.
44. Odabaei G, Chatterjee D, Jazirehi AR, Goodglick L, Yeung K and Bonavida B: Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res 91: 169-200, 2004. (Pubitemid 39140959)
45. Eckel F, Schneider G and Schmid RM: Pancreatic cancer: a review of recent advances. Expert Opin Investig Drugs 15: 1395-1410, 2006. (Pubitemid 44615288)
46. Schneider G, Siveke JT, Eckel F and Schmid RM: Pancreatic cancer: basic and clinical aspects. Gastroenterology 128: 1606-1625, 2005. (Pubitemid 40692555)
47. Escara-Wilke J, Yeung K and Keller ET: Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev: Jun 9, 2012 (Epub ahead of print).
48. Klysik J, Theroux SJ, Sedivy JM, Moffit JS and Boekelheide K: Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 20: 1-9, 2008. (Pubitemid 350138364)
49. Zeng L, Imamoto A and Rosner MR: Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets 12: 1275-1287, 2008.
50. Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W and Yeung KC: Snail is a repressor of RKIP transcription in metas-tatic prostate cancer cells. Oncogene 27: 2243-2248, 2008. (Pubitemid 351483382)
51. Fujimori Y, Inokuchi M, Takagi Y, Kato K, Kojima K and Sugihara K: Prognostic value of RKIP and p-ERK in gastric cancer. J Exp Clin Cancer Res 31: 30-38, 2012.
52. Hazgui S, Bonnomet A, Nawrocki-Raby B, Milliot M, Terryn C, Cutrona J, Polette M, Birembaut P and Zahm JM: Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells. Respir Res 9: 33-46, 2008.
53. Shankar S, Ganapathy S, Hingorani SR and Srivastava RK: EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 13: 440-452, 2008. (Pubitemid 351599756)
54. Takada Y, Andreeff M and Aggarwal BB: Indole-3-carbinol suppresses NF-κB and IκBa kinase activation, causing inhibition of expression of NF-κB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106: 641-649, 2005. (Pubitemid 40981262)
55. Jin H, Yu Y, Zhang T, Zhou X, Zhou J, Jia L, Wu Y, Zhou BP and Feng Y: Snail is critical for tumor growth and metastasis of ovarian carcinoma. Int J Cancer 126: 2102-2111, 2010.
56. Miyoshi A, Kitajima Y, Kido S, Shimonishi T, Matsuyama S, Kitahara K and Miyazaki K: Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer 92: 252-258, 2005. (Pubitemid 40343137)